QuVa Pharma is recalling 168 bags of Norepinephrine (8 mg in 250 mL), a prescription medication used to treat low blood pressure. The product was mistakenly mixed using 5% Dextrose instead of the required 0.9% Sodium Chloride solution. This error was discovered by the company and affects products distributed in California with an expiration date of January 6, 2019. Because this is a compounded medication used in clinical settings, patients should be aware of the potential for unintended reactions to the dextrose solution.
The use of 5% Dextrose instead of 0.9% Sodium Chloride as the base solution (excipient) can cause unintended blood sugar elevations or may be incompatible with other medications being administered to a patient simultaneously. While the risk is categorized as low, using the incorrect mixing solution could lead to adverse health consequences depending on a patient's underlying medical condition.
Contact healthcare provider and return for refund
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.